Excess Liver Fat in Type 2 Diabetes Stratified by Intrapancreatic Fat Deposition: A Meta-Analysis of Dual-Organ MRI Studies.
5 affiliations
- 1Department of Internal Medicine, Jersey City Medical Center/Rutgers Health, Jersey City, New Jersey, USA.
- 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
- 3Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
- 4Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
- 5School of Medicine, University of Auckland, Auckland, New Zealand.
Abstract
Both liver fat content (LFC) and intrapancreatic fat deposition (IPFD) are frequently increased in Type 2 diabetes mellitus (T2DM). We meta-analysed dual-organ MRI studies comparing LFC between individuals with T2DM and non-diabetic controls and explored whether study-level differences in LFC varied according to IPFD burden. Seventeen studies (2142 participants) were included. Individuals with T2DM had significantly higher LFC than non-diabetic controls (standardised mean difference [SMD] 0.89, 95% CI 0.60-1.18). In exploratory subgroup analyses, liver fat excess was larger in studies with mean IPFD ≥ 10% than in those with IPFD < 10% (SMD 1.20 vs. 0.62; p = 0.04), though this finding was not consistently retained in leave-one-out analyses. Alternative IPFD cutoffs yielded directionally similar but non-significant subgroup differences. Study-level differences in IPFD were associated with differences in LFC (β = 0.383, p = 0.006) in univariable meta-regression, but not after BMI adjustment. These findings suggest that higher IPFD is associated with greater liver fat excess in T2DM at the study level. Individual-level analyses are now warranted to clarify this relationship.
Related
- Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus
- GLP-1 Receptor Agonist Initiation Is Associated With Excess Skeletal Muscle Loss in Adults With Diabetes: A Prospective Population-Based MRI Study
- Adherence to the EAT-Lancet reference diet and risk of diabetes mellitus: a systematic review and dose-response meta-analysis of prospective studies
- Verification of the Short-term Effect of SGLT2 Inhibitors on Serum Magnesium Stratified by the Classification of Albuminuria Severity in Patients with Type 2 Diabetes Mellitus
- Excess hypoglycaemia-related hospitalisation in older adults with comorbid type 2 diabetes and dementia: a UK Biobank cohort study
BibTeX
@article{sul2026excess,
title = {{Excess Liver Fat in Type 2 Diabetes Stratified by Intrapancreatic Fat Deposition: A Meta-Analysis of Dual-Organ MRI Studies.}},
author = {Hyun Hee Sul and Saeed Ahmad and Pojsakorn Danpanichkul and Matheus Souza and Maxim S Petrov},
journal = {Liver international : official journal of the International Association for the Study of the Liver},
year = {2026},
month = oct,
doi = {10.1111/liv.70934},
url = {https://europepmc.org/article/MED/42897902},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Excess Liver Fat in Type 2 Diabetes Stratified by Intrapancreatic Fat Deposition: A Meta-Analysis of Dual-Organ MRI Studies.
AU - Hyun Hee Sul
AU - Saeed Ahmad
AU - Pojsakorn Danpanichkul
AU - Matheus Souza
AU - Maxim S Petrov
PY - 2026
DA - 2026/10/30
JO - Liver international : official journal of the International Association for the Study of the Liver
DO - 10.1111/liv.70934
UR - https://europepmc.org/article/MED/42897902
AB - Both liver fat content (LFC) and intrapancreatic fat deposition (IPFD) are frequently increased in Type 2 diabetes mellitus (T2DM). We meta-analysed dual-organ MRI studies comparing LFC between individuals with T2DM and non-diabetic controls and explored whether study-level differences in LFC varied according to IPFD burden. Seventeen studies (2142 participants) were included. Individuals with T2DM had significantly higher LFC than non-diabetic controls (standardised mean difference [SMD] 0.89, 95% CI 0.60-1.18). In exploratory subgroup analyses, liver fat excess was larger in studies with mean IPFD ≥ 10% than in those with IPFD < 10% (SMD 1.20 vs. 0.62; p = 0.04), though this finding was not consistently retained in leave-one-out analyses. Alternative IPFD cutoffs yielded directionally similar but non-significant subgroup differences. Study-level differences in IPFD were associated with differences in LFC (β = 0.383, p = 0.006) in univariable meta-regression, but not after BMI adjustment. These findings suggest that higher IPFD is associated with greater liver fat excess in T2DM at the study level. Individual-level analyses are now warranted to clarify this relationship.
SN - 1478-3223
SN - 1478-3231
ER -